neurotensin (8-13) has been researched along with technetium in 2 studies
| Studies (neurotensin (8-13)) | Trials (neurotensin (8-13)) | Recent Studies (post-2010) (neurotensin (8-13)) | Studies (technetium) | Trials (technetium) | Recent Studies (post-2010) (technetium) |
|---|---|---|---|---|---|
| 66 | 0 | 10 | 20,202 | 443 | 1,434 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blanc, A; Bläuenstein, P; Bruehlmeier, M; Conrath, P; García-Garayoa, E; Iterbeke, K; Schubiger, PA; Tourwé, D | 1 |
| An, R; Aruva, MR; Gao, Z; Zhang, K; Zhang, Y | 1 |
2 other study(ies) available for neurotensin (8-13) and technetium
| Article | Year |
|---|---|
Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc.
Topics: Adenocarcinoma; Animals; Female; HT29 Cells; Humans; In Vitro Techniques; Mice; Mice, Nude; Neoplasm Transplantation; Neurotensin; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Neurotensin; Structure-Activity Relationship; Technetium; Tissue Distribution | 2002 |
Radionuclide imaging of small-cell lung cancer (SCLC) using 99mTc-labeled neurotensin peptide 8-13.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Small Cell; Cell Line, Tumor; Feasibility Studies; Female; Humans; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasm Proteins; Neurotensin; Organ Specificity; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Neurotensin; Technetium; Tissue Distribution | 2006 |